(Q38209586)

31 August 2017

0 references

Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer (English)

1 reference

31 August 2017

1 reference

Bertrand Allard

1

1 reference

31 August 2017

Martin Turcotte

series ordinal

2

1 reference

31 August 2017

John Stagg

series ordinal

3

1 reference

31 August 2017

language of work or name

English

0 references

publication date

6 May 2014

1 reference

Expert Opinion on Therapeutic Targets

31 August 2017

published in

1 reference

31 August 2017

volume

18

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

863-881

1 reference

Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Pattern of metastatic spread in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Therapeutic targets in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD39 and CD73 in immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Primary structure of human placental 5'-nucleotidase and identification of the glycolipid anchor in the mature form

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

5'-Nucleotidase from the electric ray electric lobe. Primary structure and relation to mammalian and procaryotic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Characterization of soluble vs membrane-bound human placental 5'-nucleotidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Biochemical and mass spectrometric characterization of soluble ecto-5'-nucleotidase from bull seminal plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Soluble low-Km 5'-nucleotidase from electric-ray (Torpedo marmorata) electric organ and bovine cerebral cortex is derived from the glycosyl-phosphatidylinositol-anchored ectoenzyme by phospholipase C cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Characterization of different molecular forms of 5'-nucleotidase in normal serum and in serum from cholestatic patients and bile-duct-ligated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

The existence and properties of two dimers of rat liver ecto-5′-nucleotidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

5'-nucleotidase from bull seminal plasma, chicken gizzard and snake venom is a zinc metalloprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

5′-Nucleotidase: molecular structure and functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Cellular function and molecular structure of ecto-nucleotidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

X-ray structure of the Escherichia coli periplasmic 5'-nucleotidase containing a dimetal catalytic site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

E. coli 5'-nucleotidase undergoes a hinge-bending domain rotation resembling a ball-and-socket motion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Mechanism of hydrolysis of phosphate esters by the dimetal center of 5'-nucleotidase based on crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

NT5E mutations and arterial calcifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Immunity, inflammation and cancer: a leading role for adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Purinergic signaling during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Ecto-enzyme and signaling functions of lymphocyte CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73: a potent suppressor of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Interplay of hypoxia and A2B adenosine receptors in tissue protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine receptors: G protein-mediated signalling and the role of accessory proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

The resurgence of A2B adenosine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Physiological roles for ecto-5'-nucleotidase (CD73).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Transfer of the glycosylphosphatidylinositol-anchored 5'-nucleotidase CD73 from adiposomes into rat adipocytes stimulates lipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 is a major regulator of adenosinergic signalling in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine receptor signaling in the brain immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Modulation of 5'-nucleotidase activity in plasma membranes and intact cells by the extracellular matrix proteins laminin and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Ecto-5′-nucleotidase Activity Is Not Required for T Cell Activation through CD73

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 expression and fyn-dependent signaling on murine lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Anti-CD73 therapy impairs tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

The pre-metastatic niche: finding common ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73-deficient mice are resistant to carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Altered purinergic signaling in CD73-deficient mice inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Host A(2B) adenosine receptors promote carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine A2B receptor blockade slows growth of bladder and breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Role of adenosine A(2B) receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Role of estrogen receptor in the regulation of ecto-5'-nucleotidase and adenosine in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

NT5E CpG island methylation is a favourable breast cancer biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Gene expression profiling of tumor xenografts: In vivo analysis of organ‐specific metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Overexpression of Ecto-5'-Nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

An adenosine-mediated signaling pathway suppresses prenylation of the GTPase Rap1B and promotes cell scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

A new, sensitive ecto-5'-nucleotidase assay for compound screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Development of a novel ectonucleotidase assay suitable for high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

Virtual Screening Identifies Novel Sulfonamide Inhibitors of ecto-5′-Nucleotidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2014.915315

10.1517/14728222.2014.915315

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference